文献速递产科母胎医学

心脏移植受者妊娠结局:母体与新生儿发病率系统综述与Meta分析

Pregnancy outcomes in heart transplant recipients: a systematic review and meta-analysis of maternal and neonatal morbidities.
PubMed 文献 · Am J Obstet Gynecol · 2025-11-24

该系统综述与Meta分析检索PubMed、EMBASE、Cochrane图书馆和Web of Science(建库至2025年5月),纳入报告心脏移植后妊娠母胎结局的观察性队列研究,采用随机效应模型合并比例。结果显示子痫前期19.32%、早产41.36%、低出生体重37.58%、妊娠期移植物丢失5.56%、剖宫产43.35%、非计划妊娠59.45%。结论认为心脏移植后妊娠可行但高危,子痫前期显著恶化新生儿结局但不影响短期移植物存活。

要点

  • 子痫前期发生率为19.32%(95%CI 14.14-25.82;I²=0%)。
  • 早产发生率41.36%(95%CI 34.03-49.09;I²=0%),低出生体重37.58%(95%CI 30.18-45.62;I²=0.0%)。
  • 妊娠期移植物丢失率低,为5.56%(95%CI 3.10-9.75;I²=0%)。

核心结论

  • 心脏移植后妊娠可行但高危,母体发病率、早产和新生儿并发症发生率升高。
  • 子痫前期显著恶化新生儿结局,但不损害短期移植物存活。
  • 多学科管理、个体化免疫抑制管理和严格的孕前咨询对优化结局至关重要。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、Cochrane图书馆和Web of Science(建库至2025年5月)并审查参考文献列表。
  • 纳入报告既往心脏移植女性母胎妊娠结局的观察性队列研究。
  • 使用R软件进行统计分析,采用随机效应模型(DerSimonian-Laird法)估计合并比例。
  • 采用改良版纽卡斯尔-渥太华量表进行质量评估。

主要发现

  • 子痫前期发生率为19.32%(95%CI 14.14-25.82;I²=0%)。
  • 子痫前期与母体死亡率升高相关,为19.70%(95%CI 14.80-25.75;I²=0%)。
  • 早产发生率为41.36%(95%CI 34.03-49.09;I²=0%),低出生体重为37.58%(95%CI 30.18-45.62;I²=0.0%)。
  • 妊娠期移植物丢失率低,为5.56%(95%CI 3.10-9.75;I²=0%)。
  • 剖宫产率为43.35%(95%CI 36.70-50.25;I²=2.2%),非计划妊娠数据达59.45%(95%CI 38.53-77.43;I²=79%)。

临床怎么用

  • 多学科管理、个体化免疫抑制管理和严格的孕前咨询对优化结局至关重要。
  • 这些发现为心脏移植女性的临床决策和生育规划提供信息。

局限性

  • 非计划妊娠合并比例异质性I²=79%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advances in heart transplant (HT) have increased the number of reproductive-aged women with grafts considering pregnancy. However, this remains a high-risk scenario due to the potential for adverse outcomes. Current literature on comprehensive pregnancy outcomes and long-term graft implications remains limited. OBJECTIVE: To evaluate maternal and neonatal outcomes of pregnancies in heart transplant recipients. DATA SOURCES: We searched PubMed, EMBASE, the Cochrane Library, and Web of Science from their inception to May 2025 and reviewed the reference lists. STUDY ELIGIBILITY CRITERIA: We included observational cohort studies that reported maternal and fetal pregnancy outcomes in women with prior heart transplantation. STUDY APPRAISAL AND SYNTHESIS METHODS: Statistical analysis was performed using the R software; the pooled proportion was estimated using random-effects models (DerSimonian-Laird method). Quality assessment was conducted using a modified version of the Newcastle-Ottawa scale. RESULTS: Preeclampsia occurred in 19.32% (95% confidence interval, 14.14-25.82; I2=0%). and was associated with increased maternal mortality 19.70% (95% confidence interval, 14.80-25.75; I2=0%). Preterm birth 41.36% (95% confidence interval, 34.03-49.09; I2=0%) and lower birthweights (37.58%, 95% confidence interval, 30.18-45.62; I2=0.0%) were expressed. Low rates of graft loss during pregnancy were observed in 5.56% (95% confidence interval, 3.10-9.75; I2=0%). Cesareans were performed in 43.35% (95% confidence interval, 36.70-50.25; I2=2.2%), of patients, and the data of unplanned pregnancy reached 59.45% (95% confidence interval, 38.53-77.43; I2=79%) CONCLUSION: Pregnancy after HT is feasible but high-risk, with elevated rates of maternal morbidity, preterm birth, and neonatal complications. Preeclampsia significantly worsens neonatal outcomes but does not impair short-term graft survival. Multidisciplinary care, individualized immunosuppressive management, and rigorous preconception counseling are crucial for optimizing outcomes. These findings inform clinical decision-making and reproductive planning for HT women.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Albino Dos Santos Silva RR, Gomes Batista P, Ribera Chagas CV, et al. Pregnancy outcomes in heart transplant recipients: a systematic review and meta-analysis of maternal and neonatal morbidities. Am J Obstet Gynecol. 2025. PMID: 41297781. doi:10.1016/j.ajog.2025.11.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。